OR WAIT null SECS
August 02, 2018
Stem-cell developer TiGenix has been acquired by Takeda Pharmaceutical for approximately EUR 520 million (US$604 million).
August 01, 2018
The acquisition will increase Metrohm’s spectroscopy offerings and capabilities.
This article provides a sampling of the latest investments, expansions, and acquisitions by small-molecule contract service providers.
July 27, 2018
Waters’ acquisition of Prosolia’s DESI technology boosts its mass spectrometry imaging portfolio.
July 26, 2018
The acquisition would combine Sangamo’s ex vivo gene-editing capabilities with TxCell's regulatory T-cell (Treg) expertise to create chimeric antigen receptor (CAR)-Treg therapies.
July 23, 2018
The acquisition will place Cambrex into the finished dosage form CDMO market.
July 16, 2018
Otsuka Pharmaceutical will acquire Visterra, a clinical-stage biotechnology company focused on developing antibody-based therapies, for approximately $430 million.
July 11, 2018
The company has received clearance from the United States Federal Trade Commission for the proposed acquisition of Shire, a deal valued at $62 billion.
July 02, 2018
Amazon will acquire PillPack, an online pharmacy that offers pre-sorted doses of medications and home delivery.
June 29, 2018
Sanofi will sell Zentiva, its European generics business, to private equity investor Advent International.